{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:39:02Z","timestamp":1790789942648,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:00:00Z","timestamp":1573516800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:00:00Z","timestamp":1573516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS J"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1208\/s12248-019-0379-x","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T18:03:07Z","timestamp":1573581787000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Application of Item Response Theory to Model Disease Progression and Agomelatine Effect in Patients with Major Depressive Disorder"],"prefix":"10.1208","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6792-2526","authenticated-orcid":false,"given":"Marc","family":"Cerou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Peign\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Comets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marylore","family":"Chenel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,12]]},"reference":[{"key":"379_CR1","unstructured":"WHO. World Health Organisation; 2018. Available from: https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/depression. Accessed 13 Sept 2019."},{"issue":"2","key":"379_CR2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1176\/appi.ajp.157.2.229","volume":"157","author":"DA Solomon","year":"2000","unstructured":"Solomon DA, Keller MB, Leon AC, Mueller TI, Lavori PW, Shea MT, et al. Multiple recurrences of major depressive disorder. Am J Psychiatry. 2000;157(2):229\u201333.","journal-title":"Am J Psychiatry"},{"key":"379_CR3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev-publhealth-031912-114409","volume":"34","author":"RC Kessler","year":"2013","unstructured":"Kessler RC, Bromet EJ. The epidemiology of depression across cultures. Annu Rev Public Health. 2013;34:119\u201338.","journal-title":"Annu Rev Public Health"},{"issue":"4","key":"379_CR4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/jama.1996.03540040037030","volume":"276","author":"MM Weissman","year":"1996","unstructured":"Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG, et al. Cross-national epi-demiology of major depression and bipolar disorder. JAMA. 1996 Jul;276(4):293\u20139.","journal-title":"JAMA."},{"key":"379_CR5","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.socscimed.2010.03.035","volume":"71","author":"S Van de Velde","year":"2010","unstructured":"Van de Velde S, Bracke P, Levecque K. Gender differences in depression in 23 European countries. Cross-national variation in the gender gap in depression. Soc Sci Med. 2010 Jul;71:305\u201313.","journal-title":"Soc Sci Med"},{"issue":"5","key":"379_CR6","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.mcna.2014.06.013","volume":"98","author":"SM Bentley","year":"2014","unstructured":"Bentley SM, Pagalilauan GL, Simpson SA. Major depression. Med Clin N Am. 2014;98(5):981\u20131005.","journal-title":"Med Clin N Am"},{"issue":"8","key":"379_CR7","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nrd3140","volume":"9","author":"C De Bodinat","year":"2010","unstructured":"De Bodinat C, Guardiola-Lemaitre B, Moca\u00ebr E, Renard P, Mu\u00f1oz C, Millan MJ. Agomelatine, the first melatonergic antidepressant: discovery, characterization and development. Nat Rev Drug Discov. 2010;9(8):628.","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"379_CR8","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3109\/15622975.2011.595823","volume":"12","author":"G Racagni","year":"2011","unstructured":"Racagni G, Riva MA, Molteni R, Musazzi L, Calabrese F, Popoli M, et al. Mode of action of agomelatine: synergy between melatonergic and 5-HT2C receptors. World J Biol Psychiatry. 2011;12(8):574\u201387.","journal-title":"World J Biol Psychiatry"},{"issue":"10128","key":"379_CR9","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","volume":"391","author":"A Cipriani","year":"2018","unstructured":"Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018;391(10128):1357\u201366.","journal-title":"Lancet."},{"key":"379_CR10","doi-asserted-by":"crossref","first-page":"g1888","DOI":"10.1136\/bmj.g1888","volume":"348","author":"D Taylor","year":"2014","unstructured":"Taylor D, Sparshatt A, Varma S, Olofinjana O. Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies. Br Med J. 2014;348:g1888.","journal-title":"Br Med J"},{"issue":"4","key":"379_CR11","first-page":"211","volume":"191","author":"A Khan","year":"2003","unstructured":"Khan A, Detke M, Khan SR, Mallinckrodt C. Placebo response and antidepressant clinical trial outcome. J Nerv Ment Dis. 2003;191(4):211\u20138.","journal-title":"J Nerv Ment Dis"},{"issue":"10","key":"379_CR12","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.4088\/JCP.11r07485","volume":"73","author":"N Iovieno","year":"2012","unstructured":"Iovieno N, Papakostas GI. Correlation between different levels of placebo response rate and clinical trial outcome in major depressive disorder: a meta-analysis. J Clin Psychiatry. 2012;73(10):1300\u20136.","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"379_CR13","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56\u201362.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"379_CR14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0022-3956(99)00037-0","volume":"34","author":"D Faries","year":"2000","unstructured":"Faries D, Herrera J, Rayamajhi J, DeBrota D, Demitrack M, Potter WZ. The responsiveness of the Hamilton depression rating scale. J Psychiatr Res. 2000;34(1):3\u201310.","journal-title":"J Psychiatr Res"},{"issue":"12","key":"379_CR15","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1176\/appi.ajp.161.12.2163","volume":"161","author":"RM Bagby","year":"2004","unstructured":"Bagby RM, Ryder AG, Schuller DR, Marshall MB. The Hamilton depression rating scale: has the gold standard become a lead weight? Am J Psychiatry. 2004;161(12):2163\u201377.","journal-title":"Am J Psychiatry"},{"issue":"S285","key":"379_CR16","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1600-0447.1980.tb07683.x","volume":"62","author":"P Bech","year":"1980","unstructured":"Bech P, Rafaelsen O. The use of rating scales exemplified by a comparison of the Hamilton and the Bech-Rafaelsen Melancholia Scale. Acta Psychiatr Scand. 1980;62(S285):128\u201332.","journal-title":"Acta Psychiatr Scand"},{"issue":"3","key":"379_CR17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0022-3956(93)90037-3","volume":"27","author":"RD Gibbons","year":"1993","unstructured":"Gibbons RD, Clark DC, Kupfer DJ. Exactly what does the Hamilton depression rating scale measure? J Psychiatr Res. 1993;27(3):259\u201373.","journal-title":"J Psychiatr Res"},{"issue":"4","key":"379_CR18","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","volume":"134","author":"SA Montgomery","year":"1979","unstructured":"Montgomery SA, \u00c5sberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134(4):382\u20139.","journal-title":"Br J Psychiatry"},{"issue":"01","key":"379_CR19","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1055\/s-2007-1017335","volume":"18","author":"W Maier","year":"1985","unstructured":"Maier W, Philipp M. Improving the assessment of severity of depressive states: a reduction of the Hamilton Depression Scale. Pharmacopsychiatry. 1985;18(01):114\u20135.","journal-title":"Pharmacopsychiatry."},{"issue":"4","key":"379_CR20","first-page":"235","volume":"27","author":"R McIntyre","year":"2002","unstructured":"McIntyre R, Kennedy S, Bagby RM, Bakish D. Assessing full remission. J Psychiatry Neurosci. 2002;27(4):235.","journal-title":"J Psychiatry Neurosci"},{"issue":"8","key":"379_CR21","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1007\/s11095-014-1315-5","volume":"31","author":"S Ueckert","year":"2014","unstructured":"Ueckert S, Plan EL, Ito K, Karlsson MO, Corrigan B, Hooker AC, et al. Improved utilization of ADAS-cog assessment data through item response theory based pharmacometric modeling. Pharm Res. 2014;31(8):2152\u201365.","journal-title":"Pharm Res"},{"issue":"10","key":"379_CR22","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1007\/s11095-017-2216-1","volume":"34","author":"S Buatois","year":"2017","unstructured":"Buatois S, Retout S, Frey N, Ueckert S. Item response theory as an efficient tool to describe a heterogeneous clinical rating scale in de novo idiopathic Parkinson\u2019s disease patients. Pharm Res. 2017;34(10):2109\u201318.","journal-title":"Pharm Res"},{"issue":"4","key":"379_CR23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1745-3992.1997.tb00605.x","volume":"16","author":"RD Bock","year":"1997","unstructured":"Bock RD. A brief history of item theory response. J Educ Meas. 1997;16(4):21\u201333.","journal-title":"J Educ Meas"},{"issue":"1","key":"379_CR24","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13195-015-0151-0","volume":"7","author":"N Verma","year":"2015","unstructured":"Verma N, Beretvas SN, Pascual B, Masdeu JC, Markey MK. New scoring methodology improves the sensitivity of the Alzheimer\u2019s Disease Assessment Scale-Cognitive subscale (ADAS-Cog) in clinical trials. Alzheimers Res Ther. 2015;7(1):64.","journal-title":"Alzheimers Res Ther"},{"issue":"11","key":"379_CR25","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1212\/WNL.0000000000001376","volume":"84","author":"LS Schneider","year":"2015","unstructured":"Schneider LS, Kennedy RE, Wang G, Cutter GR. Differences in Alzheimer disease clinical trial outcomes based on age of the participants. Neurology. 2015;84(11):1121\u20137.","journal-title":"Neurology."},{"issue":"12","key":"379_CR26","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1037\/pas0000285","volume":"28","author":"NM Dowling","year":"2016","unstructured":"Dowling NM, Bolt DM, Deng S. An approach for estimating item sensitivity to within-person change over time: an illustration using the Alzheimer\u2019s Disease Assessment Scale-Cognitive subscale (ADAS-Cog). Psychol Assess. 2016;28(12):1576.","journal-title":"Psychol Assess"},{"issue":"1","key":"379_CR27","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1208\/s12248-016-9977-z","volume":"19","author":"AM Novakovic","year":"2017","unstructured":"Novakovic AM, Krekels EH, Munafo A, Ueckert S, Karlsson MO. Application of item response theory to modeling of expanded disability status scale in multiple sclerosis. AAPS J. 2017;19(1):172\u20139.","journal-title":"AAPS J"},{"issue":"9","key":"379_CR28","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/psp4.12219","volume":"6","author":"M Vandemeulebroecke","year":"2017","unstructured":"Vandemeulebroecke M, Bornkamp B, Krahnke T, Mielke J, Monsch A, Quarg P. A longitudinal item response theory model to characterize cognition over time in elderly subjects. CPT Pharmacometrics Syst Pharmacol. 2017;6(9):635\u201341.","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"4","key":"379_CR29","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/psp4.12156","volume":"6","author":"P V\u00e4litalo","year":"2017","unstructured":"V\u00e4litalo P, Krekels E, van Dijk M, Simons S, Tibboel D, Knibbe C. Morphine pharmacodynamics in mechanically ventilated preterm neonates undergoing endotracheal suctioning. CPT Pharmacometrics Syst Pharmacol. 2017;6(4):239\u201348.","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"3","key":"379_CR30","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1208\/s12248-017-0058-8","volume":"19","author":"G Gottipati","year":"2017","unstructured":"Gottipati G, Karlsson MO, Plan EL. Modeling a composite score in Parkinson\u2019s disease using item response theory. AAPS J. 2017;19(3):837\u201345.","journal-title":"AAPS J"},{"issue":"8","key":"379_CR31","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/psp4.12207","volume":"6","author":"E Krekels","year":"2017","unstructured":"Krekels E, Novakovic AM, Vermeulen A, Friberg LE, Karlsson MO. Item response theory to quantify longitudinal placebo and paliperidone effects on PANSS scores in schizophrenia. CPT Pharmacometrics Syst Pharmacol. 2017;6(8):543\u201351.","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"11","key":"379_CR32","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1111\/bcp.13715","volume":"84","author":"J Guk","year":"2018","unstructured":"Guk J, Chae D, Son H, Yoo J, Heo JH, Park K. Model-based assessment of the benefits and risks of recombinant tissue plasminogen activator treatment in acute ischaemic stroke. Br J Clin Pharmacol. 2018;84(11):2586\u201399.","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"379_CR33","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s10928-018-9602-0","volume":"45","author":"D Chae","year":"2018","unstructured":"Chae D, Park K. An item response theory based integrated model of headache, nausea, photophobia, and phonophobia in migraine patients. J Pharmacokinet Pharmacodyn. 2018;45(5):721\u201331.","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"379_CR34","unstructured":"Baker FB. The basics of item response theory. ERIC; 2001."},{"issue":"1","key":"379_CR35","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ejps.2008.10.025","volume":"36","author":"R Gomeni","year":"2009","unstructured":"Gomeni R, Lavergne A, Merlo-Pich E. Modelling placebo response in depression trials using a longitu-dinal model with informative dropout. Eur J Pharm Sci. 2009;36(1):4\u201310.","journal-title":"Eur J Pharm Sci"},{"issue":"8","key":"379_CR36","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.4088\/JCP.08m04548","volume":"70","author":"GM Goodwin","year":"2009","unstructured":"Goodwin GM, Emsley R, Rembry S, Rouillon F. Agomelatine prevents relapse in patients with major depressive disorder without evidence of a discontinuation syndrome: a 24-week randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2009;70(8):1128\u201337.","journal-title":"J Clin Psychiatry"},{"key":"379_CR37","doi-asserted-by":"crossref","first-page":"23S","DOI":"10.1097\/00004714-199312002-00004","volume":"13","author":"JL Claghorn","year":"1993","unstructured":"Claghorn JL, Feighner JP. A double-blind comparison of paroxetine with imipramine in the long-term treatment of depression. J Clin Psychopharmacol. 1993;13:23S\u20137S.","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"379_CR38","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.psychres.2013.10.019","volume":"215","author":"DD Mitsikostas","year":"2014","unstructured":"Mitsikostas DD, Mantonakis L, Chalarakis N. Nocebo in clinical trials for depression: a meta-analysis. Psychiatry Res. 2014;215(1):82\u20136.","journal-title":"Psychiatry Res"},{"issue":"12","key":"379_CR39","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.jpsychires.2006.09.007","volume":"41","author":"S Mazumdar","year":"2007","unstructured":"Mazumdar S, Tang G, Houck PR, Dew MA, Begley AE, Scott J, et al. Statistical analysis of longitudinal psychiatric data with dropouts. J Psychiatr Res. 2007;41(12):1032\u201341.","journal-title":"J Psychiatr Res"},{"issue":"431","key":"379_CR40","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1080\/01621459.1995.10476615","volume":"90","author":"RJ Little","year":"1995","unstructured":"Little RJ. Modeling the drop-out mechanism in repeated-measures studies. J Am Stat Assoc. 1995;90(431):1112\u201321.","journal-title":"J Am Stat Assoc"},{"issue":"1","key":"379_CR41","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1023\/A:1023249510224","volume":"30","author":"C Hu","year":"2003","unstructured":"Hu C, Sale ME. A joint model for nonlinear longitudinal data with informative dropout. J Pharmacokinet Pharmacodyn. 2003;30(1):83\u2013103.","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"1","key":"379_CR42","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1208\/s12248-014-9700-x","volume":"17","author":"MA Bj\u00f6rnsson","year":"2015","unstructured":"Bj\u00f6rnsson MA, Friberg LE, Simonsson US. Performance of nonlinear mixed effects models in the presence of informative dropout. AAPS J. 2015;17(1):245\u201355.","journal-title":"AAPS J"},{"issue":"5","key":"379_CR43","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1017\/S1461145707007766","volume":"10","author":"J Pierre Oli\u00e9","year":"2007","unstructured":"Pierre Oli\u00e9 J, Kasper S. Efficacy of agomelatine, a MT1\/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder. Int J Neuropsychopharmacol. 2007;10(5):661\u201373.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"2","key":"379_CR44","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.euroneuro.2005.09.002","volume":"16","author":"S Kennedy","year":"2006","unstructured":"Kennedy S, Emsley R. Placebo-controlled trial of agomelatine in the treatment of major depressive disorder. Eur Neuropsychopharmacol. 2006;16(2):93\u2013100.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"4","key":"379_CR45","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.euroneuro.2014.01.006","volume":"24","author":"SH Kennedy","year":"2014","unstructured":"Kennedy SH, Avedisova A, Gim\u00e9nez-Montesinos N, Bela\u00efdi C, agomelatine study group, et al. A placebo-controlled study of three agomelatine dose regimens (10 mg, 25 mg, 25-50 mg) in patients with major depressive disorder. Eur Neuropsychopharmacol. 2014;24(4):553\u201363.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"6","key":"379_CR46","doi-asserted-by":"crossref","first-page":"587","DOI":"10.4088\/JCP.12m08250","volume":"74","author":"R Heun","year":"2013","unstructured":"Heun R, Ahokas A, Boyer P, Gim\u00e9nez-Montesinos N, Pontes-Soares F, Olivier V. The efficacy of agome-latine in elderly patients with recurrent major depressive disorder: a placebo-controlled study. J Clin Psychiatry. 2013;74(6):587\u201394.","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"379_CR47","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10928-006-9035-z","volume":"34","author":"P Jacqmin","year":"2007","unstructured":"Jacqmin P, Snoeck E, Van Schaick E, Gieschke R, Pillai P, Steimer JL, et al. Modelling response time profiles in the absence of drug concentrations: definition and performance evaluation of the K-PD model. J Pharmacokinet Pharmacodyn. 2007;34(1):57\u201385.","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"379_CR48","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale: Erlbaum Associates; 1988.","edition":"2"},{"issue":"5","key":"379_CR49","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s10928-008-9098-0","volume":"35","author":"MC Kjellsson","year":"2008","unstructured":"Kjellsson MC, Zingmark PH, Jonsson EN, Karlsson MO. Comparison of proportional and differ-ential odds models for mixed-effects analysis of categorical data. J Pharmacokinet Pharmacodyn. 2008;35(5):483.","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"4","key":"379_CR50","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/psp4.12280","volume":"7","author":"S Ueckert","year":"2018","unstructured":"Ueckert S. Modeling composite assessment data using item response theory. CPT Pharmacometrics Syst Pharmacol. 2018;7(4):205\u201318.","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"5","key":"379_CR51","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1365-2125.2006.02815.x","volume":"63","author":"R Gomeni","year":"2007","unstructured":"Gomeni R, Merlo-Pich E. Bayesian modelling and ROC analysis to predict placebo responders using clinical score measured in the initial weeks of treatment in depression trials. Br J Clin Pharmacol. 2007;63(5):595\u2013613.","journal-title":"Br J Clin Pharmacol"},{"key":"379_CR52","unstructured":"Holford N, Li J, Benincosa L, Birath M. Population disease progress models for the time course of HAMD score in depressed patients receiving placebo in anti-depressant clinical trials. Abstracts of the XI annual meeting of the population approach group in Europe. 2002;Abstr. 311. Available from: www.page-meeting.org\/?abstract=311. Accessed 13 Sept 2019."},{"key":"379_CR53","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/9780470087978.ch21","volume-title":"Pharmacometrics: the science of quantitative pharmacology","author":"DR Mould","year":"2007","unstructured":"Mould DR. Developing models of disease progression. In: Ette EI, Williams PJ, editors. Pharmacometrics: the science of quantitative pharmacology; 2007. p. 547\u201381."},{"issue":"1","key":"379_CR54","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10928-009-9110-3","volume":"36","author":"EY Shang","year":"2009","unstructured":"Shang EY, Gibbs MA, Landen JW, Krams M, Russell T, Denman NG, et al. Evaluation of struc-tural models to describe the effect of placebo upon the time course of major depressive disorder. J Pharmacokinet Pharmacodyn. 2009;36(1):63\u201380.","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"379_CR55","unstructured":"Bauer JR, ICON S Development. NONMEM users guide: introduction to NONMEM 7.3.0. Maryland; 2013."},{"issue":"5","key":"379_CR56","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/clpt.2011.322","volume":"91","author":"A Russu","year":"2012","unstructured":"Russu A, Marostica E, De Nicolao G, Hooker AC, Poggesi I, Gomeni R, et al. Joint modeling of efficacy, dropout, and tolerability in flexible-dose trials: a case study in depression. Clin Pharmacol Ther. 2012;91(5):863\u201371.","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"379_CR57","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/sj.npp.1300091","volume":"28","author":"M Papp","year":"2003","unstructured":"Papp M, Gruca P, Boyer PA, Moca\u00ebr E. Effect of agomelatine in the chronic mild stress model of depression in the rat. Neuropsychopharmacology. 2003;28(4):694.","journal-title":"Neuropsychopharmacology."},{"issue":"3","key":"379_CR58","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1017\/S1461145711001301","volume":"15","author":"SP Singh","year":"2012","unstructured":"Singh SP, Singh V, Kar N. Efficacy of agomelatine in major depressive disorder: meta-analysis and appraisal. Int J Neuropsychopharmacol. 2012;15(3):417\u201328.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"3","key":"379_CR59","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1192\/bjp.bp.112.120196","volume":"203","author":"M Koesters","year":"2013","unstructured":"Koesters M, Guaiana G, Cipriani A, Becker T, Barbui C. Agomelatine efficacy and acceptability revisited: systematic review and meta-analysis of published and unpublished randomised trials. Br J Psychiatry. 2013;203(3):179\u201387.","journal-title":"Br J Psychiatry"},{"key":"379_CR60","doi-asserted-by":"crossref","unstructured":"Cusin C, Yang H, Yeung A, Fava M. Rating scales for depression. In: Handbook of clinical rating scales and assessment in psychiatry and mental health. Springer; 2009. p. 7\u201335.","DOI":"10.1007\/978-1-59745-387-5_2"}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-019-0379-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12248-019-0379-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-019-0379-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T00:09:30Z","timestamp":1605053370000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12248-019-0379-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,12]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["379"],"URL":"https:\/\/doi.org\/10.1208\/s12248-019-0379-x","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,12]]},"assertion":[{"value":"10 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"4"}}